WHO Prequalifies Bavarian Nordic's MVA-BN Vaccine as First Mpox Shot on Friday, Approved in Mexico

Sep 13, 2024, 09:45 AM

The World Health Organization (WHO) has prequalified the MVA-BN vaccine, developed by Bavarian Nordic, as the first vaccine against mpox. This approval, announced on Friday, marks a significant step towards expanding access and reducing transmission in high-risk communities. Additionally, the vaccine has been approved for emergency use in Mexico by Cofepris.